Compare Stocks

→ Gold Mania (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COP ConocoPhillips	$122.25	$123.63	$95.81 ▼ $135.18	$143.82B	1.25	5.37 million shs	5.02 million shs
CRW 506692 (CRW.TO)		C$0.00	C$0.00 ▼ C$0.40	N/A	N/A	32,717 shs	N/A
SENS Senseonics	$0.51 -1.9%	$0.53	$0.38 ▼ $1.05	$268.49M	0.91	2.44 million shs	1.50 million shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COP ConocoPhillips	-1.69%	-6.00%	-6.45%	+10.51%	+27.23%
SENS Senseonics	+12.02%	+24.24%	+1.59%	-5.11%	-11.86%

Dems have chosen Biden replacement? (Ad)

On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.

See who it is HERE.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COP ConocoPhillips	4.6968 of 5 stars	3.4	3.0	3.3	0.0	1.8	2.5	3.1
CRW 506692 (CRW.TO)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SENS Senseonics	0.7122 of 5 stars	3.0	0.0	0.0	0.0	1.8	0.0	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COP ConocoPhillips	2.81	Moderate Buy	$142.76	16.78% Upside
CRW 506692 (CRW.TO)	N/A	N/A	N/A	N/A
SENS Senseonics	2.00	Hold	$1.25	147.13% Upside

Current Analyst Ratings

Latest COP, CRW, and SENS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/3/2024	COP ConocoPhillips	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$149.00 ➝ $151.00
4/29/2024	COP ConocoPhillips	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$170.00 ➝ $160.00
4/22/2024	COP ConocoPhillips	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Positive ➝ Positive	$133.00 ➝ $154.00
4/18/2024	COP ConocoPhillips	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$145.00 ➝ $157.00
4/11/2024	COP ConocoPhillips	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$120.00 ➝ $135.00
4/10/2024	COP ConocoPhillips	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$141.00 ➝ $149.00
4/10/2024	COP ConocoPhillips	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$158.00
4/5/2024	COP ConocoPhillips	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$173.00 ➝ $170.00
3/28/2024	COP ConocoPhillips	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$123.00 ➝ $129.00
3/22/2024	COP ConocoPhillips	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$132.00 ➝ $139.00

(Data available from 5/3/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COP ConocoPhillips	$58.57B	2.46	$15.88 per share	7.70	$41.50 per share	2.95
CRW 506692 (CRW.TO)	N/A	N/A	N/A	N/A	N/A	N/A
SENS Senseonics	$22.39M	11.99	N/A	N/A	$0.07 per share	7.23

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COP ConocoPhillips	$10.96B	$9.06	13.49	11.63	2.73	18.71%	22.08%	11.46%	8/1/2024 (Estimated)
CRW 506692 (CRW.TO)	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
SENS Senseonics	-$60.39M	-$0.11	N/A	N/A	N/A	-270.13%	-146.90%	-49.81%	N/A

Latest COP, CRW, and SENS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/29/2024	Q4 2023	SENS Senseonics	-$0.04	-$0.03	+$0.01	-$0.03	$7.62 million	$8.00 million
2/8/2024	Q4 2023	COP ConocoPhillips	$2.08	$2.40	+$0.32	$2.28	$14.47 billion	$15.31 billion

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COP ConocoPhillips	$2.32	1.90%	+7.68%	25.61%	7 Years
CRW 506692 (CRW.TO)	N/A	N/A	N/A	N/A	N/A
SENS Senseonics	N/A	N/A	N/A	N/A	N/A

Latest COP, CRW, and SENS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/2/2024	COP ConocoPhillips	Quarterly	$0.78	2.55%	5/10/2024	5/13/2024	6/3/2024
2/8/2024	COP ConocoPhillips	Quarterly	$0.78	2.74%	2/15/2024	2/19/2024	3/1/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COP ConocoPhillips	0.36	1.43	1.29
CRW 506692 (CRW.TO)	N/A	N/A	N/A
SENS Senseonics	1.15	7.53	7.03

Ownership

Institutional Ownership

Company	Institutional Ownership
COP ConocoPhillips	82.36%
CRW 506692 (CRW.TO)	N/A
SENS Senseonics	12.36%

Insider Ownership

Company	Insider Ownership
COP ConocoPhillips	0.34%
CRW 506692 (CRW.TO)	N/A
SENS Senseonics	3.90%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
COP ConocoPhillips	9,900	1.18 billion	1.17 billion	Optionable
CRW 506692 (CRW.TO)	147,000	N/A	N/A	Not Optionable
SENS Senseonics	132	530.82 million	510.12 million	N/A

COP, CRW, and SENS Headlines

Source	Headline
	Senseonics Holdings, Inc. to Participate in Upcoming Conferences businesswire.com - May 2 at 8:05 AM
	Ascensia receives iCGM designation for Eversense hmenews.com - May 1 at 2:47 PM
	Bird flu testing shows more dairy products are safe, US FDA says finance.yahoo.com - May 1 at 1:19 PM
	FDA Allows Implantable CGM to Integrate With Insulin Pumps medscape.com - May 1 at 12:31 PM
	Senseonics gets FDA clearance to pair CGM implant with insulin pumps medtechdive.com - May 1 at 12:31 PM
	Eversense CGM system receives iCGM designation by FDA medicalplasticsnews.com - May 1 at 9:47 AM
	Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time finance.yahoo.com - April 30 at 7:02 PM
	Senseonics wins integrated CGM designation from FDA, can work with insulin pumps massdevice.com - April 30 at 2:08 PM
	Eversense® CGM System Receives iCGM Designation by the US FDA businesswire.com - April 30 at 7:00 AM
	Eversense® CGM System Receives iCGM Designation by the US FDA businesswire.com - April 30 at 7:00 AM
	Continuous Glucose Monitoring Market to hit USD 20 Bn by 2032, says Global Market Insights Inc. finance.yahoo.com - April 29 at 8:07 AM
	Senseonics (NYSE:SENS) Trading Up 7.8% americanbankingnews.com - April 24 at 3:00 AM
	Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies 2024 finance.yahoo.com - April 4 at 8:15 AM
	Comprehensive Market Analysis Reveals Significant Insights into the Insulin Pumps and Continuous Glucose Monitors Market Through 2033 finance.yahoo.com - April 3 at 3:17 PM
	Professional Wearable Medical Device Market: Driving Innovations in Healthcare Technology pharmiweb.com - March 15 at 9:00 AM
	Ascensia, Senseonics announce new CGM cost savings massdevice.com - March 12 at 3:02 PM
	Experts Offer CGM Tips for Type 1 Diabetes medscape.com - March 12 at 7:47 AM
	SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS prnewswire.com - March 12 at 7:00 AM
	Hand Held Glucose Meter Market – Navigating Trends and Transformations in Glucose Monitoring pharmiweb.com - March 11 at 5:22 AM
	Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes businesswire.com - March 8 at 8:05 AM
	Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference businesswire.com - March 6 at 8:05 AM
	Senseonics Holdings, Inc. (AMEX:SENS) Q4 2023 Earnings Call Transcript finance.yahoo.com - March 2 at 9:13 AM
	Senseonics slips amid concerns over demand for Eversense msn.com - March 1 at 7:41 AM
	Q4 2023 Senseonics Holdings Inc Earnings Call finance.yahoo.com - March 1 at 7:41 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

ConocoPhillips

NYSE:COP

ConocoPhillips explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas (LNG), and natural gas liquids in the United States, Canada, China, Libya, Malaysia, Norway, the United Kingdom, and internationally. The company's portfolio includes unconventional plays in North America; conventional assets in North America, Europe, Asia, and Australia; global LNG developments; oil sands assets in Canada; and an inventory of global exploration prospects. ConocoPhillips was founded in 1917 and is headquartered in Houston, Texas.

506692 (CRW.TO)

TSE:CRW

Senseonics

NYSE:SENS

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial